Abemaciclib restricts HCMV replication by suppressing pUL97-mediated phosphorylation of SAMHD1
G. Vavouras Syrigos, M. Feige, A. Dirlam, R. Businger, I. Gruska, L. Wiebusch, K. Hamprecht, M. Schindler
This study shows that Abemaciclib inhibits HCMV replication by blocking pUL97-mediated SAMHD1 phosphorylation, establishing SAMHD1 as a therapeutic target.
bioRxiv · Feb 1, 2023Microbiology